Malawi vs Saudi Arabia: Access to anti-retroviral drugs, female
Malawi
93.0%
in 2024
Saudi Arabia
91.0%
in 2024
Malawi rank
22nd
Saudi Arabia rank
25th
Access to anti-retroviral drugs, female over time
- Malawi
- Saudi Arabia
How they compare
Malawi currently reports 93.0% against 91.0% in Saudi Arabia, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Saudi Arabia ahead.
Malawi ranks 22nd and Saudi Arabia ranks 25th of 141 countries.
Across the 3 decades both report, Malawi averaged higher in 1 and Saudi Arabia in 2.
Head to head by decade
| Decade | Malawi | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.1% | 24.3% | 17.2% | Saudi Arabia |
| 2010s | 62.4% | 62.5% | 0.1% | Saudi Arabia |
| 2020s | 91.6% | 83.2% | 8.4% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Malawi or Saudi Arabia?
- Malawi, at 93.0% against 91.0% in Saudi Arabia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Malawi and Saudi Arabia?
- 2.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Malawi and Saudi Arabia rank globally for access to anti-retroviral drugs, female?
- Malawi ranks 22nd and Saudi Arabia ranks 25th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.